Jiangsu GDK Biotechnology Co Ltd (688670) — Financial Flexibility Index
Jiangsu GDK Biotechnology Co Ltd (688670) has a Financial Flexibility Index of -0.36x as of December 2024. Free cash flow of CN¥-92.91 Million (operating CF CN¥-131.39 Million minus capex CN¥38.48 Million) represents 0% of total liabilities (CN¥255.33 Million). Also explore net asset momentum of Jiangsu GDK Biotechnology Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu GDK Biotechnology Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Jiangsu GDK Biotechnology Co Ltd across 8 annual periods. Check Jiangsu GDK Biotechnology Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Jiangsu GDK Biotechnology Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Jiangsu GDK Biotechnology Co Ltd. For the full company profile including market capitalisation, see Jiangsu GDK Biotechnology Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.36x | CN¥-92.91 Million | CN¥-131.39 Million | CN¥255.33 Million | ▼ -170.3% |
| 2023 | 0.52x | CN¥134.91 Million | CN¥80.90 Million | CN¥260.52 Million | ▼ -8.1% |
| 2022 | 0.56x | CN¥206.77 Million | CN¥38.60 Million | CN¥367.11 Million | ▼ -66.3% |
| 2021 | 1.67x | CN¥490.31 Million | CN¥103.93 Million | CN¥293.12 Million | ▲ +496.1% |
| 2020 | 0.28x | CN¥150.26 Million | CN¥109.46 Million | CN¥535.47 Million | ▲ +531.0% |
| 2019 | -0.07x | CN¥-32.92 Million | CN¥-54.05 Million | CN¥505.68 Million | ▲ +10.8% |
| 2018 | -0.07x | CN¥-29.26 Million | CN¥-35.48 Million | CN¥400.73 Million | ▼ -4151.2% |
| 2017 | 0.00x | CN¥647.73K | CN¥-33.24 Million | CN¥359.39 Million | — |